Related Experiment Video
Updated: May 20, 2026
08:19
Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
In vitro biocompatibility of solid lipid nanoparticles.
Adny Henrique Silva1, Fabíola Branco Filippin-Monteiro, Bruno Mattei
1Departamento de Ciências Farmacêuticas, Universidade Federal de Santa Catarina P.O. Box 476, Florianópolis, SC, 88040-900, Brazil.
The Science of the Total Environment
|July 4, 2012
Summary
This study assessed cellular responses to solid lipid nanoparticles (SLNs). While most SLNs were biocompatible, formulation F5 exhibited significant cytotoxicity, potentially due to sodium dodecyl sulfate (SDS).
Area of Science:
- Nanotechnology
- Cell Biology
- Toxicology
Background:
- Limited understanding of cellular responses to solid lipid nanoparticles (SLNs).
- Need to evaluate the biocompatibility of various SLN formulations for safe application.
Purpose of the Study:
- Investigate the cytotoxicity of different SLN formulations on fibroblast cell lines (Vero and MDCK).
- Elucidate the mechanisms underlying SLN-induced cellular damage.
Main Methods:
- Cell viability assays (MTT, LDH).
- Flow cytometry for cell cycle analysis and apoptosis detection.
- Reactive oxygen species (ROS) generation assessment.
- Mitochondrial membrane potential evaluation.
Main Results:
- SLN formulations F4 and F5 showed significant cytotoxicity in both Vero and MDCK cells.
- F4 and F5 impacted mitochondrial metabolism and lysosomal activity.
- F5 induced DNA fragmentation in MDCK cells and demonstrated lower IC50 (~250 μg/mL), possibly due to SDS.
- F4 affected mitochondrial membrane potential in Vero cells (IC50 ~700 μg/mL).
Conclusions:
- Most tested SLN formulations appear biocompatible, except for F5.
- F5 exhibits notable cytotoxicity, warranting further investigation into its specific components like SDS.
- Further in vivo studies are necessary to assess the overall safety and predict the implications of widespread SLN use.
